«Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor». J. Mol. Endocrinol.19 (3): 207–26. 1997. doi:10.1677/jme.0.0190207. PMID9460643.
«Molecular basis of agonism and antagonism in the oestrogen receptor». Nature389 (6652): 753–8. 1997. doi:10.1038/39645. PMID9338790.
«The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen». Cell95 (7): 927–37. 1998. doi:10.1016/S0092-8674(00)81717-1. PMID9875847.
«Principles for modulation of the nuclear receptor superfamily». Nature reviews. Drug discovery3 (11): 950–64. 2004. doi:10.1038/nrd1551. PMID15520817.
«Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha». J. Med. Chem.47 (23): 5593–6. 2004. doi:10.1021/jm049334f. PMID15509154.
«Coregulator function: a key to understanding tissue specificity of selective receptor modulators». Endocr Rev25 (1): 45–71. 2004. doi:10.1210/er.2003-0023. PMID14769827.
«Nuclear receptors versus inflammation: mechanisms of transrepression». Trends Endocrinol Metab17 (8): 321–7. 2006. doi:10.1016/j.tem.2006.08.005. PMID16942889.
«Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor». J. Mol. Endocrinol.19 (3): 207–26. 1997. doi:10.1677/jme.0.0190207. PMID9460643.
«Molecular basis of agonism and antagonism in the oestrogen receptor». Nature389 (6652): 753–8. 1997. doi:10.1038/39645. PMID9338790.
«The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen». Cell95 (7): 927–37. 1998. doi:10.1016/S0092-8674(00)81717-1. PMID9875847.
«Principles for modulation of the nuclear receptor superfamily». Nature reviews. Drug discovery3 (11): 950–64. 2004. doi:10.1038/nrd1551. PMID15520817.
«Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha». J. Med. Chem.47 (23): 5593–6. 2004. doi:10.1021/jm049334f. PMID15509154.
«Coregulator function: a key to understanding tissue specificity of selective receptor modulators». Endocr Rev25 (1): 45–71. 2004. doi:10.1210/er.2003-0023. PMID14769827.
«Nuclear receptors versus inflammation: mechanisms of transrepression». Trends Endocrinol Metab17 (8): 321–7. 2006. doi:10.1016/j.tem.2006.08.005. PMID16942889.